Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers (2010)
- Autores:
- Autores USP: ROCHA, ADRIANA - FCFRP ; COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FCFRP; FMRP
- DOI: 10.1111/j.1365-2125.2010.03649.x
- Assunto: FARMACOCINÉTICA
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título do periódico: British Journal of Clinical Pharmacology
- ISSN: 0306-5251
- Volume/Número/Paginação/Ano: v. 70, n. 1, p. 43-51, 2010
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
ROCHA, Adriana et al. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British Journal of Clinical Pharmacology, v. 70, n. 1, p. 43-51, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2125.2010.03649.x. Acesso em: 13 maio 2024. -
APA
Rocha, A., Coelho, E. B., Sampaio, S. A., & Lanchote, V. L. (2010). Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers. British Journal of Clinical Pharmacology, 70( 1), 43-51. doi:10.1111/j.1365-2125.2010.03649.x -
NLM
Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers [Internet]. British Journal of Clinical Pharmacology. 2010 ; 70( 1): 43-51.[citado 2024 maio 13 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03649.x -
Vancouver
Rocha A, Coelho EB, Sampaio SA, Lanchote VL. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers [Internet]. British Journal of Clinical Pharmacology. 2010 ; 70( 1): 43-51.[citado 2024 maio 13 ] Available from: https://doi.org/10.1111/j.1365-2125.2010.03649.x - Omeprazole inhibits preferentially the metabolism of the (+)-(S)-citalopram eutomer in healthy volunteers
- Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers
- LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses
- Enantioselective pharmacokinetics of lercanidipine in healthy volunteers
- Influence of lercanidipine in the kinetic sisposition of fluvastatin enantiomers in healthy volunteers
- Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: application to pharmacokinetics
- Analysis of carvedilol enantiomers in human plasma using chiral stationary phase column and liquid chromatography with tandem mass spectrometry
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
Informações sobre o DOI: 10.1111/j.1365-2125.2010.03649.x (Fonte: oaDOI API)
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
